NCT00441675View on ClinicalTrials.gov

A Long Term Prospective Follow Up Study For The CATO Study (SAS30018/SER9702)

CompletedOBSERVATIONAL
Enrollment

137

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

October 31, 2007

Study Completion Date

October 31, 2007

Conditions
Asthma
Interventions
PROCEDURE

Symptom Score

Symptom Score

PROCEDURE

Symptom Score and PD20

Symptom Score and PD20

Trial Locations (15)

1815 JD

GSK Investigational Site, Alkmaar

1315 RA

GSK Investigational Site, Almere Stad

1081 HV

GSK Investigational Site, Amsterdam

1105 AZ

GSK Investigational Site, Amsterdam

4819 EV

GSK Investigational Site, Breda

9713 GZ

GSK Investigational Site, Groningen

1213 VX

GSK Investigational Site, Hilversum

2333 ZA

GSK Investigational Site, Leiden

6229 HX

GSK Investigational Site, Maastricht

3015 GJ

GSK Investigational Site, Rotterdam

6131 BK

GSK Investigational Site, Sittard

2566 MJ

GSK Investigational Site, The Hague

3584 EA

GSK Investigational Site, Utrecht

5504 DB

GSK Investigational Site, Veldhoven

8025 AB

GSK Investigational Site, Zwolle

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY